SCHMC

A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)

Metadata Downloads
All Author(s)
Y. H. Park ; T. Y. Kim ; G. M. Kim ; K. H. Jung ; S. Y. Kang ; I. H. Park ; J. H. Kim ; K. E. Lee ; H. K. Ahn ; M. H. Lee ; H. J. Kim ; J. I. Lee ; S. J. Koh ; J. Y. Kim ; K. H. Lee ; J. Sohn ; S. B. Kim ; Y. H. Im ; S. A. Im
Intsitutional Author(s)
김한조
Issued Date
2019
Type
Conference
Conference Name
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference Date
43616
dc_citation_conferenceCountry
Chicago, IL, United States
Citation Publisher
American Society of Clinical Oncology
Citation Title
Journal of Clinical Oncology. Volume 37, Number 15_suppl
Citation Start Page
1007
Citation End Page
1007
Language(ISO)
eng
DOI
10.1200/JCO.2019.37.15_suppl.1007
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4539
Appears in Collections:
종양혈액내과 > 2. Conference Papers
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.